Safety of growth hormone treatment in patients previously treated for cancer

Wassim Chemaitilly; Leslie L Robison

doi:10.1016/j.ecl.2012.07.002

Safety of growth hormone treatment in patients previously treated for cancer

Endocrinol Metab Clin North Am. 2012 Dec;41(4):785-92. doi: 10.1016/j.ecl.2012.07.002. Epub 2012 Sep 13.

Authors

Wassim Chemaitilly¹, Leslie L Robison

Affiliation

¹ Division of Endocrinology, Department of Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN 38105-3678, USA. wassim.chemaitilly@stjude.org

PMID: 23099270
DOI: 10.1016/j.ecl.2012.07.002

Abstract

This review provides an overview of the safety of growth hormone replacement therapy in individuals previously treated for cancer. The review focuses on the risk of disease recurrence and second neoplasm occurrence with special attention to data on childhood cancer survivors.

Publication types

Review

MeSH terms

Adult
Brain Neoplasms / complications
Brain Neoplasms / etiology
Child
Growth Disorders / drug therapy
Growth Disorders / etiology
Growth Hormone / adverse effects*
Hormone Replacement Therapy / adverse effects*
Humans
Meningioma / etiology
Neoplasm Recurrence, Local / etiology
Neoplasms / therapy*
Neoplasms, Radiation-Induced / etiology
Neoplasms, Second Primary / etiology
Radiotherapy / adverse effects
Survivors

Substances

Growth Hormone